ADIM
ENTG icon

Alpha DNA Investment Management’s Entegris ENTG Stock Holding History

Alpha DNA Investment Management’s Portfolio ENTG Stock Details ENTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,108
Closed -$1.49M – 117
2021
Q2 		$1.49M Buy
12,108
+6,829
+129% +$785K 1.02% 40
2021
Q1 		$589K Sell
5,279
-2,487
-32% -$256K 0.68% 83
2020
Q4 		$746K Buy
+7,766
New +$678K 0.79% 53

Other funds holding ENTG

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Alpha DNA Investment Management's ENTG Position: Q3 2021 in Review

Alpha DNA Investment Management sold out of Entegris (ENTG) in Q3 2021, closing a stake of 12,108 shares — an estimated $1.49M sold.

Alpha DNA Investment Management first reported a position in ENTG in Q4 2020 and held it in 3 quarters. The position peaked at $1.49M in Q2 2021. 450 funds tracked by Wall St. Rank hold ENTG as of Q3 2021.

  • Alpha DNA Investment Management reported no remaining Entegris position as of Q3 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 12,108 Entegris shares in Q3 2021, an estimated $1.49M.
  • Alpha DNA Investment Management first reported a position in Entegris in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Entegris position peaked at $1.49M in Q2 2021.
  • 450 funds tracked by Wall St. Rank held Entegris as of Q3 2021.

Based on Alpha DNA Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.